Is a patient with elevated Parathyroid Hormone (PTH) of 84.7, low Thyroid-Stimulating Hormone (TSH) of 0.58, vitamin D deficiency of 18.1, and hypercalcemia of 10.2 possibly suffering from primary hyperparathyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for Elevated PTH and Calcium Levels

The patient's laboratory results show an elevated parathyroid hormone (PTH) level of 84.7, a low thyroid-stimulating hormone (TSH) level of 0.58, a vitamin D level of 18.1, and a calcium level of 10.2. Based on these findings, the following differential diagnoses are considered:

  • Single Most Likely Diagnosis

    • Primary Hyperparathyroidism: This condition is characterized by an elevated PTH level, which leads to increased calcium levels in the blood. The patient's PTH and calcium levels are consistent with this diagnosis. The low vitamin D level may also contribute to the elevated PTH, as vitamin D deficiency can lead to secondary hyperparathyroidism, but the primary cause appears to be an overproduction of PTH.
  • Other Likely Diagnoses

    • Vitamin D Deficiency: Although the vitamin D level is not severely low, it is still below the normal range. Vitamin D deficiency can lead to secondary hyperparathyroidism, which may contribute to the elevated PTH and calcium levels.
    • Familial Hypocalciuric Hypercalcemia (FHH): This is a rare genetic disorder that affects calcium metabolism and can lead to elevated PTH and calcium levels. However, it is less likely than primary hyperparathyroidism.
  • Do Not Miss Diagnoses

    • Malignancy-Associated Hypercalcemia: Certain types of cancer, such as parathyroid carcinoma, can produce PTH-related protein (PTHrP), leading to hypercalcemia. Although less likely, this diagnosis is critical to rule out due to its potential severity.
    • Lithium-Induced Hyperparathyroidism: Lithium therapy can cause hyperparathyroidism, and it is essential to consider this possibility, especially if the patient has a history of lithium use.
  • Rare Diagnoses

    • Multiple Endocrine Neoplasia (MEN) Syndromes: These are rare genetic disorders that can affect multiple endocrine glands, including the parathyroid glands, leading to hyperparathyroidism.
    • Parathyroid Carcinoma: This is a rare cause of primary hyperparathyroidism, but it is essential to consider due to its potential severity and impact on treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.